Richard D. Gordon

16.7k total citations · 2 hit papers
289 papers, 11.2k citations indexed

About

Richard D. Gordon is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Richard D. Gordon has authored 289 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Endocrinology, Diabetes and Metabolism, 121 papers in Surgery and 62 papers in Molecular Biology. Recurrent topics in Richard D. Gordon's work include Hormonal Regulation and Hypertension (152 papers), Adrenal and Paraganglionic Tumors (97 papers) and Adrenal Hormones and Disorders (49 papers). Richard D. Gordon is often cited by papers focused on Hormonal Regulation and Hypertension (152 papers), Adrenal and Paraganglionic Tumors (97 papers) and Adrenal Hormones and Disorders (49 papers). Richard D. Gordon collaborates with scholars based in Australia, United States and United Kingdom. Richard D. Gordon's co-authors include Michael Stowasser, Terry J. Tunny, Shelley A. Klemm, John C. Rutherford, Ashraf Ahmed, Grant W. Liddle, S. A. Klemm, Anthony W. Bachmann, Donald P. Island and Martin Wolley and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Richard D. Gordon

283 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents

2004 686 citations Michael Stowasser, Richard D. Gordon et al. profile →
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

2018 669 citations Richard D. Gordon, Eduardo A. Albornoz et al. profile →

Peers

Richard D. Gordon

EDM

SURGE

CCM

PRM

Benjamin Gläser Israel

Mitsuhide Naruse Japan

Celso E. Gómez-Sánchez United States

Lydia Aguilar‐Bryan United States

Debra I. Diz United States

G. Pozza Italy

Susumu Seino Japan

Jürgen Schnermann United States

John W. Funder Australia

Toru Aizawa Japan

Benjamin Gläser Israel

Richard D. Gordon

4.5k ×0.7

EDM

4.8k ×0.9

SURGE

4.4k ×1.7

364 ×0.2

CCM

497 ×0.5

PRM

Citations per year, relative to Richard D. Gordon Richard D. Gordon (= 1×) peers Benjamin Gläser

Countries citing papers authored by Richard D. Gordon

Since Specialization

Citations

This map shows the geographic impact of Richard D. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Gordon more than expected).

Fields of papers citing papers by Richard D. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Gordon. The network helps show where Richard D. Gordon may publish in the future.

Co-authorship network of co-authors of Richard D. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Gordon. A scholar is included among the top collaborators of Richard D. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Gordon. Richard D. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Albornoz, Eduardo A., Richard D. Gordon, Ibrahim Javed, et al.. (2025). Microglial Complement C5aR1 signalling drives inflammasome mediated neuropathology in Parkinson’s disease. Immunobiology. 230(4). 152955–152955.

Albornoz, Eduardo A., Karine Mardon, Rajiv Bhalla, et al.. (2025). PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models. Brain.

Oronsky, Bryan, Lori H. Takahashi, Richard D. Gordon, et al.. (2023). RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist. Frontiers in Oncology. 13. 1204143–1204143. 14 indexed citations

Lee, John D., Eduardo A. Albornoz, Luke McAlary, et al.. (2019). The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 68(2). 407–421. 154 indexed citations

Gordon, Richard D., Matthew L. Neal, Jie Luo, et al.. (2016). Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration. Nature Communications. 7(1). 12932–12932. 72 indexed citations

Jin, Huajun, et al.. (2016). p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity. NeuroToxicology. 59. 231–239. 15 indexed citations

Brennan, Faith H., Richard D. Gordon, Stephen M. Taylor, et al.. (2015). The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury. Journal of Neuroscience. 35(16). 6517–6531. 87 indexed citations

Goupil, Rémi, Stelios Fountoulakis, Richard D. Gordon, & Michael Stowasser. (2015). Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. Journal of Hypertension. 33(11). 2286–2293. 1 indexed citations

Ahmed, Ashraf, et al.. (2011). Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. Queensland's institutional digital repository (The University of Queensland). 7 indexed citations

10.

Gordon, Richard D., Huajun Jin, Vellareddy Anantharam, et al.. (2011). Neuroprotective Effect of Resveratrol Against Methamphetamine-Induced Dopaminergic Apoptotic Cell Death in a Cell Culture Model of Neurotoxicity. Current Neuropharmacology. 9(1). 49–53. 40 indexed citations

11.

Gordon, Richard D.. (2010). Insights into Slavery and Abolition in an Eighteenth-Century Portuguese Interlude: Novo, e devertido Entremez Intitulado O contentamento Dos Pretos Por terem a sua Alforria. Bulletin of Hispanic Studies. 87(8). 995–1020. 1 indexed citations

12.

Gordon, Richard D., Colleen Hogan, Matthew L. Neal, et al.. (2010). A simple magnetic separation method for high-yield isolation of pure primary microglia. Journal of Neuroscience Methods. 194(2). 287–296. 74 indexed citations

13.

Stowasser, Michael & Richard D. Gordon. (2003). Primary aldosteronism—careful investigation is essential and rewarding. Molecular and Cellular Endocrinology. 217(1-2). 33–39. 127 indexed citations

14.

Stowasser, Michael & Richard D. Gordon. (2002). The Aldosterone-Renin Ratio and Primary Aldosteronism. Mayo Clinic Proceedings. 77(2). 202–202. 6 indexed citations

15.

Krum, Henry, Richard D. Gordon, H Nolly, et al.. (2002). Co-Administration of Eplerenone with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin II Antagonist in Patients with Mild to Moderate Hypertension. Japanese Circulation Journal-english Edition. 66. 561. 6 indexed citations

16.

Guan, Huaiqun, Richard D. Gordon, & Yunping Zhu. (1998). Combining various projection access schemes with the algebraic reconstruction technique for low-contrast detection in computed tomography. Physics in Medicine and Biology. 43(8). 2413–2421. 20 indexed citations

17.

Bachmann, Anthony W., et al.. (1990). EFFECT OF GRADED ADRENALINE INFUSION ON ARTERIAL ADRENALINE CLEARANCE IN NORMOTENSIVE AND HYPERTENSIVE MAN. Clinical and Experimental Pharmacology and Physiology. 17(4). 257–261. 2 indexed citations

18.

Gordon, Richard D., et al.. (1989). Infusions of Adrenaline Stimulate Noradrenergic Transmission in Man, But Adrenaline is not Released Later as A Co-Transmitter. Clinical and Experimental Hypertension Part A Theory and Practice. 11(sup1). 329–335. 4 indexed citations

19.

Finn, Wendy L., Richard D. Gordon, Terry J. Tunny, Shelley A. Klemm, & Stephen Hamlet. (1988). EFFECTS OF VOLUME EXPANSION AND CONTRACTION ON PLASMA LEVELS OF ATRIAL NATRIURETIC PEPTIDE IN MAN. Clinical and Experimental Pharmacology and Physiology. 15(4). 311–315. 17 indexed citations

20.

Tunny, Terry J., S. A. Klemm, & Richard D. Gordon. (1987). EFFECTS OF ANGIOTENSIN AND NORADRENALINE ON ATRIAL NATRIURETIC PEPTIDE LEVELS IN MAN. Clinical and Experimental Pharmacology and Physiology. 14(3). 221–225. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact